आपके बैज 52W रेंज $354–$557 36% of range विश्लेषक रेटिंग HOLD 30 analysts मूल्य लक्ष्य $454 +6% upside P/E 14.3 ROE -124.0% शुद्ध लाभ मार्जिन 8.8%

HCA स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा

03
मूल्य $426.69
मार्केट कैप (MRQ) $93.00B
P/E (TTM) 14.3
EPS (TTM) $29.82
राजस्व (TTM) $78.01B
लाभांश प्रतिफल 0.71%
ROE (TTM) -124.0%
D/E ऋण/इक्विटी (MRQ) -6.5
52W रेंज $354–$557

HCA स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें

04
सीमा
बार

बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।

HCA Healthcare, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन

05 · wikidata

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗

Wikidata ↗

क्षेत्रHealth Care उद्योगHealth Care कर्मचारी230000 देशUS

10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान

06
राजस्व$75.60B
2016-12-31 → 2025-12-31
EPS$28.33
2016-12-31 → 2025-12-31
फ्री कैश फ्लो$7.69B
2016-12-31 → 2025-12-31
शुद्ध मार्जिन8.8%
2018-12-31 → 2025-12-31
मूल्यांकन और अनुपात 07–12

मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?

मेट्रिक 5Y रुझान HCA 5Y औसत सहकर्मी माध्यिका निर्णय
P/E (TTM) 14.35Y औसत ≈13.8 ≈13.8 16.5 अल्पमूल्यित
P/S (TTM) 1.25Y औसत ≈1.2 ≈1.2 1.2 उचित मूल्य
P/B (MRQ) -14.05Y औसत ≈-39.2 ≈-39.2 · ·
EV / EBITDA 38.75Y औसत ≈37.3 ≈37.3 18.9 अति मूल्यांकित
मूल्य / FCF (TTM) 15.55Y औसत ≈14.6 ≈14.6 · ·
मूल्य / नकदी प्रवाह (TTM) 8.45Y औसत ≈7.9 ≈7.9 9.1 अल्पमूल्यित
EV / Revenue (EV / राजस्व) 1.85Y औसत ≈1.8 ≈1.8 · ·
EV / FCF 17.75Y औसत ≈21.8 ≈21.8 · ·
PEG Ratio (PEG अनुपात) ≈0.7 · · ·

सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।

मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय

लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR

13
लाभांश यील्ड0.71%
भुगतान अनुपात10.0%
वार्षिक भुगतान≈$3.12तिमाही भुगतान
5Y लाभांश CAGR≈21.9%प्रति शेयर, विभाजन-समायोजित
विकास की लकीर≈5लाभांश वृद्धि के लगातार वर्ष
एक्स-डेटराशिमुद्रायील्ड
सित 16, 2026$0.78USD≈0.71%
जून 16, 2026$0.78USD≈0.76%
मा 17, 2026$0.78USD≈0.58%
दिस् 15, 2025$0.72USD≈0.60%
सित 16, 2025$0.72USD≈0.71%
जून 16, 2025$0.72USD≈0.75%
मा 17, 2025$0.72USD≈0.82%
दिस् 13, 2024$0.66USD≈0.84%
सित 16, 2024$0.66USD≈0.64%
जून 14, 2024$0.66USD≈0.75%
मा 14, 2024$0.66USD≈0.76%
दिस् 13, 2023$0.60USD≈0.89%
सित 14, 2023$0.60USD≈0.90%
जून 15, 2023$0.60USD≈0.81%
मा 16, 2023$0.60USD≈0.90%
दिस् 13, 2022$0.56USD≈0.92%
सित 15, 2022$0.56USD≈1.0%
जून 15, 2022$0.56USD≈1.1%
मा 16, 2022$0.56USD≈0.75%
दिस् 13, 2021$0.48USD≈0.90%

Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि

14
औसत आश्चर्य 7.9%
अगली रिपोर्ट अक्ट 22, 2026
Periodरिपोर्टEPS ActualEPS अनुमानआश्चर्य
30 जून 2026 जुल 23, 2026 $7.62 $7.54 1.0%
31 मार्च 2026 $7.15 $7.21 -0.85%
31 दिसमबर 2025 $8.14 $7.53 8.0%
30 सितमबर 2025 $6.96 $5.77 20.6%
30 जून 2025 $6.83 $6.31 8.2%
31 मार्च 2025 $6.45 $5.84 10.5%

पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह

15
आय विवरण 12
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
SG&A Expense $548M$421M$353M$307M$337M$416M$370M$344M$340M$343M
Operating Expenses $65.77B$62.08B$57.26B$51.65B$48.92B$46.10B$46.09B$41.34B$39.23B$36.68B
Interest Expense $2.25B$2.06B$1.94B$1.74B$1.57B$1.58B$1.82B$1.75B$1.69B$1.71B
Pretax Income $9.83B$8.52B$7.71B$8.58B$9.83B$5.43B$5.24B$5.33B$4.38B$4.81B
Income Tax $2.05B$1.87B$1.61B$1.75B$2.11B$1.04B$1.10B$946M$1.64B$1.38B
Net Income $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
EPS (Basic) $28.70$22.27$19.25$19.43$21.52$11.10$10.27$10.90$6.12$7.53
EPS (Diluted) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Shares (Basic) 236,413,000258,603,000272,404,000290,348,000323,315,000338,274,000341,210,000347,297,000362,305,000383,591,000
Shares (Diluted) 239,495,000261,806,000276,412,000294,666,000328,752,000343,605,000348,226,000355,303,000372,221,000395,851,000
EBITDA $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
बैलेंस शीट 22
मेट्रिक रुझान 2025202420232022202120202019201820172016
Cash & Equivalents $1.04B$1.93B$935M$908M$1.45B$1.79B$621M$502M$732M$646M
Short-term Investments ·····$116M$147M$47M$54M$49M
Receivables $10.87B$10.75B$9.96B$8.89B$8.10B$7.05B$7.38B$6.79B$6.50B$5.83B
Inventory $1.65B$1.74B$2.02B$2.07B$1.99B$2.02B$1.85B$1.73B$1.57B$1.50B
Other Current Assets $2.22B$1.99B$2.01B$1.78B$2.01B$1.46B$1.35B$1.19B$1.17B$1.11B
Current Assets $15.78B$16.41B$14.93B$13.64B$13.54B$12.33B$11.20B$10.21B$9.98B$9.09B
PP&E (Net) $31.14B$29.41B$27.71B$25.57B$24.06B$23.20B$22.71B$19.76B$17.89B$16.35B
PP&E (Gross) $66.28B$62.51B$58.55B$54.76B$51.35B$49.32B$47.23B$42.97B$40.08B$37.05B
Accum. Depreciation $35.13B$33.10B$30.83B$29.18B$27.29B$26.12B$24.52B$23.21B$22.19B$20.70B
Other Non-current Assets $255M$230M$184M$298M$598M$546M$480M$690M$710M$1.07B
Total Assets $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Accounts Payable $4.66B$4.28B$4.23B$4.24B$4.11B$3.54B$2.90B$2.58B$2.61B$2.32B
Current Liabilities $16.35B$15.18B$12.65B$9.90B$9.58B$8.70B$7.76B$7.57B$6.16B$5.83B
Capital Leases $1.85B$1.86B$1.90B$1.75B$1.75B$1.67B$1.50B···
Total Liabilities ······$45.62B$42.12B$41.59B$39.39B
Long-term Debt $44.28B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Total Debt $41.60B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Retained Earnings $-5.72B$-2.12B$-1.35B$-2.28B$-532M$777M$-2.35B$-4.57B$-6.53B$-6.97B
AOCI $-305M$-387M$-425M$-490M$-404M$-502M$-460M$-381M$-278M$-338M
Stockholders' Equity $-6.03B$-2.50B$-1.77B$-2.77B$-933M$572M$-2.81B$-4.95B$-6.81B$-7.30B
Liabilities + Equity $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Shares Outstanding 224,605,100249,981,400265,537,300277,378,300305,476,800339,425,600338,445,600342,895,200350,091,600370,535,900
नकदी प्रवाह 17
मेट्रिक रुझान 2025202420232022202120202019201820172016
D&A $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Stock-based Comp $401M$360M$262M$341M$440M$362M$347M$268M$270M$251M
Amort. of Intangibles $12M$16M$20M$44M$25M$26M····
Other Non-cash $1.93B$1.08B$850M$-431M$-1.29B$2.40B$1.07B$461M$-3.53B$-2.67B
Operating Cash Flow $12.64B$10.51B$9.43B$8.52B$8.96B$9.23B$7.60B$6.76B$5.43B$5.65B
CapEx $4.94B$4.88B$4.74B$4.39B$3.58B$2.83B$4.16B$3.57B$3.02B$2.76B
Investing Cash Flow $-4.99B$-4.93B$-5.32B$-3.39B$-2.64B$-3.39B$-5.72B$-3.90B$-4.28B$-3.24B
Debt Issued $8.47B$7.50B$3.22B$6.00B$4.34B$2.70B$6.45B$2.00B$1.50B$5.40B
Net Debt Issued $1.08B$5.08B$2.31B$3.17B$475M$-737M$1.13B$296M$749M$925M
Stock Repurchased $10.07B$6.04B$3.81B$7.00B$8.21B$441M$1.03B$1.53B$2.05B$2.75B
Net Stock Activity $-10.07B$-6.04B$-3.81B$-7.00B$-8.21B$-441M$-1.03B$-1.53B$-2.05B$-2.75B
Dividends Paid $679M$690M$661M$653M$624M$153M$550M$487M$0·
Financing Cash Flow $-8.55B$-4.58B$-4.09B$-5.66B$-6.66B$-4.68B$-1.77B$-3.08B$-1.06B$-2.51B
Net Change in Cash $-893M$998M$27M$-543M$-342M$1.17B$119M$-230M$86M$-95M
Taxes Paid $1.74B$1.84B$1.39B$1.18B$2.18B$1.00B$849M$872M$1.21B$1.25B
Free Cash Flow $7.69B$5.64B$4.69B$4.13B$5.38B$6.40B$3.44B$3.19B$2.41B$2.89B
Levered FCF $5.91B$4.03B$3.16B$2.74B$4.15B$5.12B$2.00B$1.74B$1.35B$1.68B
लाभप्रदता 5
मेट्रिक रुझान 2025202420232022202120202019201820172016
Net Margin 9.0%8.2%8.1%9.4%11.8%7.3%6.8%8.1%··
Pretax Margin 13.0%12.1%11.9%14.2%16.7%10.5%10.2%11.4%··
EBITDA Margin 4.7%4.7%4.7%4.9%4.9%5.3%5.1%4.9%··
ROA 11.3%10.0%9.7%10.9%14.2%8.1%8.3%10.0%6.3%8.7%
ROE -159.1%-269.6%-230.9%-305.0%-3853.7%-335.8%-90.4%-64.4%-31.4%-38.8%
तरलता और शोधन क्षमता 4
मेट्रिक रुझान 2025202420232022202120202019201820172016
Current Ratio 1.01.11.21.41.41.41.41.31.61.6
Quick Ratio 0.70.80.91.01.01.01.11.01.21.1
Debt / Equity -6.9-17.2-22.3-13.8-37.154.2-12.0-6.6-4.9-4.3
LT Debt / Equity -6.9-15.3-21.0-13.6-36.853.8-12.0-6.5-4.8-4.3
दक्षता 2
मेट्रिक रुझान 2025202420232022202120202019201820172016
Asset Turnover 1.31.21.21.21.21.11.21.2··
Receivables Turnover 7.06.86.97.17.87.17.27.0··
प्रति शेयर 6
मेट्रिक रुझान 2025202420232022202120202019201820172016
Book Value / Share $-26.83$-10.00$-6.68$-9.98$-3.05$1.69$-8.30$-14.44$-19.44$-19.71
Revenue / Share $315.66$269.68$235.04$204.41$178.71$149.98$147.42$131.37··
Cash Flow / Share $52.76$40.16$34.12$28.92$27.25$26.87$21.83$19.03$14.58$14.28
Cash / Share $4.63$7.73$3.52$3.27$4.75$5.28$1.83$1.46$2.09$1.74
Dividend / Share $2.88$2.64$2.40$2.24$1.92$0.43$1.60$1.40··
EPS (TTM) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
विकास दरें 10
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue YoY 7.1%8.7%7.9%2.5%14.0%·····
Revenue CAGR 3Y 7.9%6.3%8.0%·······
Revenue CAGR 5Y 8.0%·········
EPS YoY 28.8%16.0%-0.94%-9.5%93.6%·····
EPS CAGR 3Y 13.9%1.3%20.2%·······
EPS CAGR 5Y 21.0%·········
Net Income YoY 17.8%9.9%-7.1%-18.9%85.3%·····
Net Income CAGR 3Y 6.3%-6.1%11.8%·······
Net Income CAGR 5Y 12.6%·········
Dividends Paid CAGR 5Y 34.7%·········
मूल्यांकन (TTM) 17
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue TTM $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
Net Income TTM $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
Market Cap $104.86B$75.03B$71.88B$66.56B$78.48B$55.82B$50.03B$42.67B$30.75B$27.43B
Enterprise Value $145.42B$116.13B$110.53B$103.74B$111.61B$84.92B$82.98B$74.95B$63.02B$58.11B
P/E 16.513.614.312.512.115.014.711.714.810.1
P/S 1.41.11.11.11.31.11.00.90.70.7
P/B -17.4-30.0-40.5-24.1-84.197.6-17.8-8.6-4.5-3.8
P / Tangible Book ·····97.6····
P / Cash Flow 8.37.17.67.88.86.06.66.35.74.9
P / FCF 13.613.315.316.114.68.714.513.412.89.5
EV / EBITDA 41.335.135.934.939.131.232.032.929.629.6
EV / FCF 18.920.623.625.120.713.324.123.526.120.1
EV / Revenue 1.91.61.71.71.91.61.61.61.41.4
Dividend Yield 0.65%0.92%0.92%0.98%0.80%0.27%1.1%1.1%0.00%·
Earnings Yield 6.1%7.3%7.0%8.0%8.2%6.7%6.8%8.6%6.8%9.9%
Payout Ratio 10.0%12.0%12.6%11.6%9.0%4.1%15.7%12.9%··
Annual Payout $679M$690M$661M$653M$624M$153M$550M$487M$0·

सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·

वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष

16
मेट्रिक 2025-12-312024-12-312023-12-312022-12-312021-12-31
राजस्व $75.60B $70.60B $64.97B $60.23B $58.75B
शुद्ध आय $6.78B $5.76B $5.24B $5.64B $6.96B
तनुकरणित EPS $28.33 $22.00 $18.97 $19.15 $21.16

संस्थागत मालिक (13F) 1473 फाइलर्स · $57.3B कुल · तिथि अनुसार 30 सितमबर 2026

17

संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।

धारक 1473
धारित मूल्य $57.3B
नई स्थितियाँ 121
बाहर निकली पोजीशन 176
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
नई स्थितियाँ बाहर निकली पोजीशन बढ़ाया घटा हुआ शुद्ध शेयर परिवर्तन
121 (-64 पिछली तिमाही की तुलना में) 176 (+72 पिछली तिमाही की तुलना में) 458 (-25 पिछली तिमाही की तुलना में) 581 (+4 पिछली तिमाही की तुलना में) -627K

Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।

संस्था मूल्य शेयर % ट्रैक किए गए 13F का प्रकार
VANGUARD GROUP INC $6870392526 14716173 12.00% शेयर
BlackRock, Inc. $5069973824 13003600 8.85% शेयर
VANGUARD CAPITAL MANAGEMENT LLC $3954150533 10141708 6.91% शेयर
Sanders Capital, LLC $3442060818 8828287 6.01% शेयर
STATE STREET CORP $2912102056 7469035 5.09% शेयर
WELLINGTON MANAGEMENT GROUP LLP $1835396649 4707473 3.21% शेयर
GEODE CAPITAL MANAGEMENT, LLC $1423654808 3668008 2.49% शेयर
First Eagle Investment Management, LLC $1284907912 3295565 2.24% शेयर
VANGUARD PORTFOLIO MANAGEMENT LLC $1057704509 2712828 1.85% शेयर
MORGAN STANLEY $1008556857 2586771 1.76% शेयर
GOLDMAN SACHS GROUP INC $960811481 2464314 1.68% शेयर
JPMORGAN CHASE & CO $896800955 2285832 1.57% शेयर
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861456107 2209485 1.50% शेयर
NORGES BANK $836457140 2145367 1.46% शेयर
Capital World Investors $770864224 1977121 1.35% शेयर
Capital International Investors $747403041 1916947 1.31% शेयर
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $709859997 1500000 1.24% शेयर
NORTHERN TRUST CORP $666150458 1708560 1.16% शेयर
FMR LLC $636503475 1632520 1.11% शेयर
Invesco Ltd. $596390232 1529637 1.04% शेयर
NORDEA INVESTMENT MANAGEMENT AB $553702529 1429943 0.97% शेयर
BARCLAYS PLC $514349127 1319216 0.90% शेयर
JANUS HENDERSON GROUP PLC $481486890 1017441 0.84% शेयर
Crake Asset Management LLP $449072183 1151792 0.78% शेयर
Metropolis Capital Ltd $430915307 910564 0.75% शेयर
Darsana Capital Partners LP $428879000 1100000 0.75% शेयर
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414565358 1063288 0.72% शेयर
Legal & General Group Plc $410992402 1054124 0.72% शेयर
FRANKLIN RESOURCES INC $399958688 1025824 0.70% शेयर
Life Cycle Investment Partners Ltd $355737196 912404 0.62% शेयर
Bank of New York Mellon Corp $350359895 898612 0.61% शेयर
VANGUARD FIDUCIARY TRUST CO $339685814 871235 0.59% शेयर
ROYAL BANK OF CANADA $320194000 821241 0.56% शेयर
LYRICAL ASSET MANAGEMENT LP $255015742 654071 0.45% शेयर
BANK OF AMERICA CORP /DE/ $238456934 611601 0.42% शेयर
SCHRODER INVESTMENT MANAGEMENT GROUP $237236367 608470 0.41% शेयर
ROYAL LONDON ASSET MANAGEMENT LTD $235649908 604401 0.41% शेयर
PRINCIPAL FINANCIAL GROUP INC $234827401 602290 0.41% शेयर
UBS Group AG $230953291 592355 0.40% शेयर
National Pension Service $230650346 591578 0.40% शेयर
Russell Investments Group, Ltd. $206832565 530340 0.36% शेयर
Nuveen, LLC $199595109 511927 0.35% शेयर
Gobi Capital LLC $195742325 502045 0.34% शेयर
Cryder Capital Partners LLP $194561738 499017 0.34% शेयर
Allianz Asset Management GmbH $181127299 464560 0.32% शेयर
DEUTSCHE BANK AG\ $175985429 451372 0.31% शेयर
Swiss National Bank $172097446 441400 0.30% शेयर
DIMENSIONAL FUND ADVISORS LP $172079393 441313 0.30% शेयर
AustralianSuper Pty Ltd $159635782 409438 0.28% शेयर
HSBC HOLDINGS PLC $158555065 406750 0.28% शेयर

सभी 1473 संस्थागत मालिक दिखाएँ →

कार्यकर्ता और 5%+ मालिक 4 होल्डिंग्स

18

जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।

फाइलर दाखिल किया दांव स्थिति उद्देश्य फाइलिंग
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 फ़रवरी 2026 31.60% प्रारंभिक फाइलिंग · SEC
22 नवमबर 2006 · प्रारंभिक फाइलिंग · SEC
Merrill Lynch Bank USA 11 सितमबर 2006 · प्रारंभिक फाइलिंग · SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 4 अगस्त 2006 · प्रारंभिक फाइलिंग · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

कंपनी के अंदरूनी सूत्र 92 इनसाइडर्स · 54 अधिकारी · 31 निदेशक

19
अंदरूनी भूमिका अंतिम गतिविधि शेयरों का स्वामित्व खरीद 12m बिक्री 12m नेट 12m
Samuel N Hazen CEO 10 फ़रवरी 2026 F 64842 0 7 $-21483290
O'Boyle Michael P President & CEO - Parallon 26 फ़रवरी 2013 A 21429 0 0 $0
Mike A Marks EVP and CFO 7 मई 2026 G 46576 0 0 $0
Bill B Rutherford CFO and EVP 16 फ़रवरी 2024 F 22251 0 0 $0
Russell K Harms CFO - Central Group 17 नवमबर 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 नवमबर 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 नवमबर 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 1 जुलाई 2005 F 13865 0 0 $0
Erol R Akdamar Group President 12 नवमबर 2024 M 6843 0 0 $0
Timothy M Mcmanus Group President 31 जुलाई 2024 M 27008 0 0 $0
Richard A Hammett Group President 16 फ़रवरी 2024 F 17936 0 0 $0
Charles J Hall Group President 11 नवमबर 2022 M 202443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 नवमबर 2022 S 30807 0 0 $0
Paul W Rutledge Group President 31 दिसमबर 2012 A 335657 0 0 $0
Beverly B Wallace President - Parallon 2 नवमबर 2011 M 144714 0 0 $0
Charles Robert Evans President - Eastern Group 26 जुलाई 2006 A 62173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 अक्टूबर 2005 A 26154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 अक्टूबर 2004 D 9029 0 0 $0
Jay Grinney President-Eastern Group 7 मई 2004 D 24177 0 0 $0
Jon M Foster EVP and COO 10 फ़रवरी 2026 F 23062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 26 अगस्त 2026 J 0 0 2 $-2747520
Jennifer Berres SVP & Chief Human Res. Officer 11 फ़रवरी 2026 S 11993 0 2 $-4126932
Christopher F. Wyatt SVP & Controller 11 फ़रवरी 2026 S 44379 0 1 $-2020000
Erica Rossitto SVP & Chief Nurse Executive 10 फ़रवरी 2026 F 10407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 फ़रवरी 2026 F 32080 0 1 $-747135
Sammie S Mosier SVP & Chief Nurse Executive 13 फ़रवरी 2025 F 11113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 नवमबर 2024 S 9454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 नवमबर 2024 M 52702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 5 अगस्त 2024 G 18526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 जुलाई 2024 S 3510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 जुलाई 2024 S 17755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 9 मई 2024 S 5185 0 0 $0
Chad J Wasserman SVP and CIO 18 मार्च 2024 M 1576 0 0 $0
Martin P. Paslick SVP and CIO 12 अप्रैल 2023 M 24643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 9 नवमबर 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 5 मई 2021 S 50062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 फ़रवरी 2021 F 5578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 फ़रवरी 2021 F 10122 0 0 $0
Victor L Campbell SVP-Government Affairs 1 मई 2019 A 194145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 फ़रवरी 2019 M 84157 0 0 $0
Milton R Johnson Chairman 25 फ़रवरी 2019 M 881823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 फ़रवरी 2018 M 7003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 फ़रवरी 2018 M 35546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 फ़रवरी 2018 M 65199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 मई 2017 M 26378 0 0 $0
David Gwin Anderson SVP - Finance 7 नवमबर 2016 M 110167 0 0 $0
Donald W Stinnett SVP & Controller 25 फ़रवरी 2016 A 51965 0 0 $0
Noel B Williams SVP and CIO 16 मई 2012 M 299030 0 0 $0
Jack O Bovender JR Chairman 6 अक्टूबर 2009 A 188340 0 0 $0
Carl V George SVP - Development 27 फ़रवरी 2009 M 13092 0 0 $0
Patricia T Lindler SVP - Government Programs 17 नवमबर 2006 D 0 0 0 $0
Rosalyn S Elton SVP-Operations Finance 17 नवमबर 2006 D 0 0 0 $0
Frank M Houser MD SVP-Quality & Medical Director 26 जुलाई 2006 A 46145 0 0 $0
James A Fitzgerald JR SVP-Supply Chain Operations 29 जनवरी 2006 F 20674 0 0 $0
Andrea B Smith निदेशक 28 अप्रैल 2026 A 4666 0 0 $0
William R Frist निदेशक 28 अप्रैल 2026 A 13740 0 0 $0
Wayne Joseph Riley निदेशक 28 अप्रैल 2026 A 15029 0 0 $0
Hugh F Johnston निदेशक 28 अप्रैल 2026 A 4475 0 0 $0
Thomas F Frist III निदेशक 28 अप्रैल 2026 A 15858 0 0 $0
Michael W Michelson निदेशक 28 अप्रैल 2026 A 12576 0 0 $0
Nancy Ann Deparle निदेशक 28 अप्रैल 2026 A 21910 0 0 $0
John Chidsey निदेशक 28 अप्रैल 2026 A 1305 0 0 $0
Robert J Dennis निदेशक 29 अप्रैल 2025 A 26601 0 0 $0
Meg Crofton निदेशक 29 अप्रैल 2024 A 6331 0 0 $0
Charles O Holliday JR निदेशक 25 अप्रैल 2022 A 18955 0 0 $0
Geoffrey G Meyers निदेशक 1 मई 2019 A 39153 0 0 $0
John W Rowe निदेशक 1 मई 2019 A 30388 0 0 $0
Ann H Lamont निदेशक 2 मई 2018 A 17661 0 0 $0
Jay O Light निदेशक 3 मई 2017 A 30953 0 0 $0
Stephen G Pagliuca निदेशक 5 दिसमबर 2014 D 7612921 0 0 $0
Christopher R Gordon निदेशक 1 नवमबर 2013 D 30003156 0 0 $0
John Connaughton निदेशक 1 नवमबर 2013 D 30003156 0 0 $0
John H Mcarthur निदेशक 17 नवमबर 2006 D 0 0 0 $0
Kent C Nelson निदेशक 17 नवमबर 2006 D 0 0 0 $0
Magdalena Averhoff MD निदेशक 17 नवमबर 2006 D 0 0 0 $0
Glenda A Hatchett निदेशक 17 नवमबर 2006 D 0 0 0 $0
Frederick W Gluck निदेशक 17 नवमबर 2006 D 0 0 0 $0
Harold T Shapiro निदेशक 17 नवमबर 2006 D 0 0 0 $0
Michael C Armstrong निदेशक 17 नवमबर 2006 D 0 0 0 $0
Martin Feldstein निदेशक 17 नवमबर 2006 D 0 0 0 $0
Michael T Long निदेशक 17 नवमबर 2006 D 0 0 0 $0
ROYAL FRANK S निदेशक 17 नवमबर 2006 D 0 0 0 $0
Patricia F Elcan 10% मालिक 6 फ़रवरी 2026 J 36557141 0 0 $0
Frisco Holding II 10% मालिक 6 फ़रवरी 2026 J 36557141 0 0 $0
HERCULES HOLDING II, LLC 10% मालिक 6 फ़रवरी 2026 J 32282889 0 0 $0
Thomas F Frist JR 10% मालिक 6 फ़रवरी 2026 J 36557141 0 0 $0
Patricia C Frist 10% मालिक 20 फ़रवरी 2018 G 0 0 0 $0
KKR PEI GP LTD 10% मालिक 1 अप्रैल 2014 J 0 0 0 $0
Jonathan B Perlin · 2 अगस्त 2021 S 44348 0 0 $0
Juan Vallarino · 9 मई 2016 M 61036 0 0 $0
Richard M Bracken · 31 दिसमबर 2014 F 82499 0 0 $0
BANK OF AMERICA CORP /DE/ · 6 नवमबर 2012 S 2652364 0 0 $0

SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S

ईटीएफ स्वामित्व 141 ETFs द्वारा धारित

20

वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।

फंड भार इकाइयाँ तिथि अनुसार स्रोत
BUL · Pacer Funds Trust 5.07% 16545 NS 31 जुलाई 2026 N-PORT
IHF · iShares Trust 4.75% 147977 SH 11 सितमबर 2026 दैनिक
STNC · Hennessy Funds Trust 3.17% 7315 NS 31 जुलाई 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2.45% 97235 SH 2 अक्टूबर 2026 दैनिक
COWZ · Pacer Funds Trust 2.07% 960711 NS 31 जुलाई 2026 N-PORT
WLTG · ETF Opportunities Trust 2.06% 3942 NS 31 जुलाई 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1.66% 34083 SH 2 अक्टूबर 2026 दैनिक
RPG · Invesco Exchange-Traded Fund Trust 1.27% 58580 SH 2 अक्टूबर 2026 दैनिक
FLAG · Global X Funds 1.14% 48 NS 31 जुलाई 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1.03% 6909 NS 31 जुलाई 2026 N-PORT
IYH · iShares Trust 1.01% 87417 SH 11 सितमबर 2026 दैनिक
SRHQ · Elevation Series Trust 0.94% 4938 NS 31 जुलाई 2026 N-PORT
NEAR · iShares U.S. ETF Trust 0.92% 48109000 SH 11 सितमबर 2026 दैनिक
FHLC · FIDELITY COVINGTON TRUST 0.91% 74445 NS 31 जुलाई 2026 N-PORT
VHT · VANGUARD WORLD FUND 0.90% 470451 SH 19 अगस्त 2026 दैनिक
FXH · First Trust Exchange-Traded AlphaDE… 0.87% 22725 NS 31 जुलाई 2026 N-PORT
DIVB · iShares Trust 0.87% 42100 SH 11 सितमबर 2026 दैनिक
NFRA · FlexShares Trust 0.84% 62628 NS 31 जुलाई 2026 N-PORT
IXJ · iShares Trust 0.83% 81708 SH 11 सितमबर 2026 दैनिक
SPVM · Invesco Exchange-Traded Fund Trust 0.80% 2483 SH 2 अक्टूबर 2026 दैनिक
QUVU · Hartford Funds Exchange-Traded Trust 0.79% 3522 NS 31 जुलाई 2026 N-PORT
BSCT · Invesco Exchange-Traded Self-Indexe… 0.78% 23458000 2 अक्टूबर 2026 दैनिक
BSCS · Invesco Exchange-Traded Self-Indexe… 0.74% 25897000 1 अक्टूबर 2026 दैनिक
CURE · Direxion Shares ETF Trust 0.72% 3056 NS 31 जुलाई 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0.67% 12075 SH 19 अगस्त 2026 दैनिक
LGDX · Tidal Trust III 0.66% 2345 NS 31 जुलाई 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.55% 11876 SH 19 अगस्त 2026 दैनिक
BSCR · Invesco Exchange-Traded Self-Indexe… 0.50% 23126000 2 अक्टूबर 2026 दैनिक
LSVD · ADVISORS' INNER CIRCLE FUND 0.46% 7404 NS 31 जुलाई 2026 N-PORT
WLDR · Two Roads Shared Trust 0.43% 964 NS 31 जुलाई 2026 N-PORT
ROUS · Lattice Strategies Trust 0.42% 7289 NS 31 जुलाई 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0.40% 92161 SH 2 अक्टूबर 2026 दैनिक
QLC · FlexShares Trust 0.39% 9856 NS 31 जुलाई 2026 N-PORT
XOEF · iShares Trust 0.37% 194 SH 11 सितमबर 2026 दैनिक
GSY · Invesco Actively Managed Exchange-T… 0.36% 14000000 2 अक्टूबर 2026 दैनिक
UPSD · ETF Series Solutions 0.33% 972 NS 31 जुलाई 2026 N-PORT
BSCU · Invesco Exchange-Traded Self-Indexe… 0.33% 9324000 2 अक्टूबर 2026 दैनिक
MGV · VANGUARD WORLD FUND 0.29% 97604 SH 19 अगस्त 2026 दैनिक
PFIG · Invesco Exchange-Traded Fund Trust … 0.28% 390000 2 अक्टूबर 2026 दैनिक
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0.28% 3186 NS 31 जुलाई 2026 N-PORT
USXF · iShares Trust 0.26% 9226 SH 11 सितमबर 2026 दैनिक
IUS · Invesco Exchange-Traded Self-Indexe… 0.26% 5813 SH 2 अक्टूबर 2026 दैनिक
IWX · iShares Trust 0.23% 21535 SH 11 सितमबर 2026 दैनिक
VTV · VANGUARD INDEX FUNDS 0.23% 1475731 SH 19 अगस्त 2026 दैनिक
JMOM · J.P. Morgan Exchange-Traded Fund Tr… 0.23% 14235 NS 31 जुलाई 2026 N-PORT
MPLY · Strategy Shares 0.22% 87 NS 31 जुलाई 2026 N-PORT
EUSA · iShares, Inc. 0.21% 9589 SH 11 सितमबर 2026 दैनिक
RSP · Invesco Exchange-Traded Fund Trust 0.21% 462724 SH 2 अक्टूबर 2026 दैनिक
FTC · First Trust Exchange-Traded AlphaDE… 0.20% 6420 NS 31 जुलाई 2026 N-PORT
SIZE · iShares Trust 0.19% 1920 SH 11 सितमबर 2026 दैनिक
DYNF · BlackRock ETF Trust 0.19% 183934 SH 11 सितमबर 2026 दैनिक
VMAX · Lattice Strategies Trust 0.19% 228 NS 31 जुलाई 2026 N-PORT
DSI · iShares Trust 0.19% 23734 SH 11 सितमबर 2026 दैनिक
ILCV · iShares Trust 0.18% 5870 SH 10 सितमबर 2026 दैनिक
IVW · iShares Trust 0.18% 331185 SH 11 सितमबर 2026 दैनिक
IUSG · iShares Trust 0.17% 136713 SH 11 सितमबर 2026 दैनिक
VOOG · VANGUARD ADMIRAL FUNDS 0.17% 115334 SH 19 अगस्त 2026 दैनिक
IWD · iShares Trust 0.17% 332035 SH 11 सितमबर 2026 दैनिक
VONV · VANGUARD SCOTTSDALE FUNDS 0.16% 90157 SH 19 अगस्त 2026 दैनिक
OMFL · Invesco Exchange-Traded Self-Indexe… 0.16% 17773 SH 2 अक्टूबर 2026 दैनिक
USMV · iShares Trust 0.16% 89855 SH 11 सितमबर 2026 दैनिक
ACWV · iShares, Inc. 0.15% 11903 SH 11 सितमबर 2026 दैनिक
EGLE · Global X Funds 0.15% 8 NS 31 जुलाई 2026 N-PORT
GLBL · Pacer Funds Trust 0.15% 4 NS 31 जुलाई 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0.14% 33327 SH 2 अक्टूबर 2026 दैनिक
VOXP · Advisors Series Trust 0.13% 18 NS 31 जुलाई 2026 N-PORT
VRIG · Invesco Actively Managed Exchange-T… 0.12% 2250000 1 अक्टूबर 2026 दैनिक
TOPC · iShares Trust 0.12% 95 SH 11 सितमबर 2026 दैनिक
DGRO · iShares Trust 0.12% 120741 SH 11 सितमबर 2026 दैनिक
XVV · iShares Trust 0.11% 1790 SH 11 सितमबर 2026 दैनिक
QVML · Invesco Exchange-Traded Fund Trust … 0.11% 4410 SH 2 अक्टूबर 2026 दैनिक
IWL · iShares Trust 0.11% 5786 SH 11 सितमबर 2026 दैनिक
MGC · VANGUARD WORLD FUND 0.11% 31176 SH 19 अगस्त 2026 दैनिक
ACIO · ETF Series Solutions 0.11% 6205 NS 31 जुलाई 2026 N-PORT
EVUS · iShares Trust 0.10% 934 SH 11 सितमबर 2026 दैनिक
ADME · ETF Series Solutions 0.10% 751 NS 31 जुलाई 2026 N-PORT
XRMI · Global X Funds 0.10% 126 NS 31 जुलाई 2026 N-PORT
XCLR · Global X Funds 0.10% 9 NS 31 जुलाई 2026 N-PORT
XYLD · Global X Funds 0.10% 8148 NS 31 जुलाई 2026 N-PORT
XTR · Global X Funds 0.10% 12 NS 31 जुलाई 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0.10% 13621 NS 31 जुलाई 2026 N-PORT
VV · VANGUARD INDEX FUNDS 0.10% 181364 SH 19 अगस्त 2026 दैनिक
ESGV · VANGUARD WORLD FUND 0.10% 33758 SH 19 अगस्त 2026 दैनिक
IVV · iShares Trust 0.10% 1957485 SH 11 सितमबर 2026 दैनिक
PBUS · Invesco Exchange-Traded Fund Trust … 0.10% 26839 SH 2 अक्टूबर 2026 दैनिक
PTLC · Pacer Funds Trust 0.10% 7919 NS 31 जुलाई 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0.10% 1395 NS 31 जुलाई 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0.10% 877 SH 2 अक्टूबर 2026 दैनिक
ILCB · iShares Trust 0.10% 2915 SH 11 सितमबर 2026 दैनिक
EQAL · Invesco Exchange-Traded Fund Trust … 0.10% 1794 SH 2 अक्टूबर 2026 दैनिक
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0.09% 20766 NS 31 जुलाई 2026 N-PORT
IYY · iShares Trust 0.09% 6693 SH 11 सितमबर 2026 दैनिक
VOTE · TCW ETF Trust 0.09% 2545 NS 31 जुलाई 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0.09% 3614 NS 31 जुलाई 2026 N-PORT
XYLG · Global X Funds 0.09% 147 NS 31 जुलाई 2026 N-PORT
DFUS · Dimensional ETF Trust 0.09% 46791 NS 31 जुलाई 2026 N-PORT
IWB · iShares Trust 0.09% 103721 SH 11 सितमबर 2026 दैनिक
VOO · VANGUARD INDEX FUNDS 0.09% 4034357 SH 19 अगस्त 2026 दैनिक
TOV · EA Series Trust 0.09% 607 NS 31 जुलाई 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0.09% 586 NS 31 जुलाई 2026 N-PORT
ITOT · iShares Trust 0.09% 202387 SH 11 सितमबर 2026 दैनिक
ACVF · ETF Opportunities Trust 0.09% 337 NS 31 जुलाई 2026 N-PORT
GTOS · Invesco Actively Managed Exchange-T… 0.09% 104000 2 अक्टूबर 2026 दैनिक
QDPL · Pacer Funds Trust 0.09% 3708 NS 31 जुलाई 2026 N-PORT
IWV · iShares Trust 0.09% 41034 SH 11 सितमबर 2026 दैनिक
DFAU · Dimensional ETF Trust 0.08% 25516 NS 31 जुलाई 2026 N-PORT
CRBN · iShares Trust 0.08% 2269 SH 11 सितमबर 2026 दैनिक
TOK · iShares Trust 0.08% 451 SH 11 सितमबर 2026 दैनिक
VTI · VANGUARD INDEX FUNDS 0.08% 4930930 SH 19 अगस्त 2026 दैनिक
VONE · VANGUARD SCOTTSDALE FUNDS 0.08% 24633 SH 19 अगस्त 2026 दैनिक
VTHR · VANGUARD SCOTTSDALE FUNDS 0.08% 12577 SH 19 अगस्त 2026 दैनिक
PHDG · Invesco Actively Managed Exchange-T… 0.08% 116 SH 2 अक्टूबर 2026 दैनिक
HCMT · Direxion Shares ETF Trust 0.08% 1081 NS 31 जुलाई 2026 N-PORT
TILT · FlexShares Trust 0.08% 4108 NS 31 जुलाई 2026 N-PORT
SPXL · Direxion Shares ETF Trust 0.07% 12141 NS 31 जुलाई 2026 N-PORT
URTH · iShares, Inc. 0.07% 14079 SH 11 सितमबर 2026 दैनिक
ACWI · iShares Trust 0.06% 50294 SH 11 सितमबर 2026 दैनिक
HDUS · Lattice Strategies Trust 0.05% 275 NS 31 जुलाई 2026 N-PORT
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.05% 125729 SH 19 अगस्त 2026 दैनिक
DCOR · Dimensional ETF Trust 0.05% 3816 NS 31 जुलाई 2026 N-PORT
GLOF · iShares Trust 0.04% 202 SH 11 सितमबर 2026 दैनिक
DUHP · Dimensional ETF Trust 0.04% 10761 NS 31 जुलाई 2026 N-PORT
DFAC · Dimensional ETF Trust 0.02% 28662 NS 31 जुलाई 2026 N-PORT
DFSU · Dimensional ETF Trust 0.02% 1127 NS 31 जुलाई 2026 N-PORT
DXUV · Dimensional ETF Trust 0.01% 99 NS 31 जुलाई 2026 N-PORT
GTO · Invesco Actively Managed Exchange-T… 0.00% 42000 30 सितमबर 2026 दैनिक
CBLS · Elevation Series Trust -1.12% -1546 NS 31 जुलाई 2026 N-PORT
BIV · VANGUARD BOND INDEX FUNDS · · 15 जुलाई 2026 दैनिक
BLV · VANGUARD BOND INDEX FUNDS · · 15 जुलाई 2026 दैनिक
BSV · VANGUARD BOND INDEX FUNDS · · 15 जुलाई 2026 दैनिक
BND · VANGUARD BOND INDEX FUNDS · · 15 जुलाई 2026 दैनिक
VUSB · VANGUARD BOND INDEX FUNDS · · 15 जुलाई 2026 दैनिक
VCRB · VANGUARD MALVERN FUNDS · · 15 जुलाई 2026 दैनिक
VPLS · VANGUARD MALVERN FUNDS · · 15 जुलाई 2026 दैनिक
VSDB · VANGUARD MALVERN FUNDS · · 15 जुलाई 2026 दैनिक
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 जुलाई 2026 दैनिक
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 जुलाई 2026 दैनिक
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 जुलाई 2026 दैनिक
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 जुलाई 2026 दैनिक
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 जुलाई 2026 दैनिक
VCEB · VANGUARD WORLD FUND · · 30 जुलाई 2026 दैनिक

HCA विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड

21
रेटिंग · 30 विश्लेषक खरीदें
मध्यिका लक्ष्य $450.00 +5.5%
6 20.0% मजबूत खरीद
11 36.7% खरीदें
12 40.0% होल्ड
1 3.3% बेचें
0 0.0% मजबूत बिक्री

12-महीने का मूल्य लक्ष्य

22 विश्लेषक · 2026-09-28

माध्य लक्ष्य $454.23 +6.5%

अभी वर्तमान मूल्य $426.69
निम्न$380.00 माध्य$454.23 उच्च$579.00

सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी

22

वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।

टिकर मार्केट कैप P/E राजस्व YoY शुद्ध मार्जिन ROE सकल मार्जिन
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·
THC $17.28B 12.8 3.1% 11.1% 56.4% ·
EHC $10.61B 19.2 10.5% 9.5% 25.1% ·
UHS · 9.4 9.7% 8.6% 21.4% ·
ENSG $10.12B 29.8 18.7% 6.8% 16.9% ·
PACS $6.01B 31.5 29.3% 3.6% 23.1% ·
CON $2.53B 15.1 13.9% 7.7% 49.8% ·
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9% ·
SNDA $612M -7.7 25.2% -18.6% -197.2% ·

ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां

23

ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत

25

अभी कोई खुला सिग्नल नहीं — कोई कार्ड भरा नहीं है, और यह ईमानदार है।

मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ

26

उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।

आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।

स्रोत: SEC 10-Q जुल 28, 2026 को फाइल किया गया